Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the non-therapeutic biomolecules market?

The scale of the non-therapeutic biomolecules market has seen a swift increase in recent times. The market, currently worth $30.76 billion in 2024, is anticipated to reach $34.23 billion in 2025, witnessing a compound annual growth rate (CAGR) of 11.3%. The robust growth observed during the historical phase is primarily due to escalated investments in research and development (R&D), expanding utilization in research and diagnostics, growing awareness and acceptance, strategic alliances and partnerships, and regulatory backing.

What will be the non-therapeutic biomolecules market size in the future?

The market size for non-therapeutic biomolecules is anticipated to experience swift expansion in the coming years, reaching $52.15 billion in 2029 with a compound annual growth rate (CAGR) of 11.1%. The predicted growth during this period can be attributed to developing market opportunities, improvements in data analytics and integration, an increased emphasis on precision medicine, amplified investment in personalized healthcare, and broadening application areas. Key trends for the forecast period encompass technological progression, strategic partnerships, increasing uses in agriculture, a growing function in industrial processes, customization, and personalization.

Get your non-therapeutic biomolecules market report here!

https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

What main drivers are fueling expansion in the non-therapeutic biomolecules market?

The escalating count of research work along with laboratory tests are potentially contributing to the advancement of the non-therapeutic biomolecules market. This form of laboratory assessment pertains to a medical process where certain samples like blood or urine, among others, are examined to formulate a treatment plan based on the determination and monitoring of a disease. Conversely, research involves conjuring up new ideas and applying current knowledge creatively for new understandings or concepts. Non-therapeutic biomolecules, when applied in the realm of laboratory testing, assist in ascertaining the presence or level of a biomarker molecule, characteristic of a disease, thus fine-tuning the accuracy of the test outcomes. For instance, data from the National Health Service (NHS), UK’s health care provider, revealed that diagnostic activity in July 2024 surpassed the pre-pandemic rates recorded in 2023, showing a 21% rise in tests conducted in May 2024 compared to the previous year. As a result, the non-therapeutic biomolecules market is experiencing growth driven by the progressively increasing research work and laboratory tests.

What key areas define the segmentation of the global non-therapeutic biomolecules market?

The non-therapeutic biomolecules market covered in this report is segmented –

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies

2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:

1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes

2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors

3) By Plasmids: Research Plasmids, Expression Plasmids

4) By Peptides: Antimicrobial Peptides, Signaling Peptides

5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides

6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

Who are the dominant players expanding their reach in the non-therapeutic biomolecules market?

Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

How are evolving market trends shaping non-therapeutic biomolecules Strategies?

The emergence of product innovations is a prevailing trend observed in the non-therapeutic biomolecules industry. To maintain their market stance, key companies are focusing on research and development to innovate new products. For instance, in January 2022, BASF SE, a German multinational chemical corporation, collaborated with Caregen, a Korean biomimetic peptide research and development firm. Together, they launched the Peptovitae series, produced with liposome-encapsulation technology, to broaden their dermo-cosmetics offerings and present inventive and distinctive solutions for diverse skin issues. By utilizing liposomal encapsulation, a method that employs fats to carry essential vitamins or drugs in minuscule bubbles to particular areas of the body without disturbing other sections, the Peptovitae series can address a broader assortment of skin ailments beyond traditional peptide applications. This includes signs of ageing, improving skin luminosity, relieving dry and itchy skin, and hydrating the skin.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8769

Which regions are emerging as leaders in the non-therapeutic biomolecules market?

Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Scientific Research And Development Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/scientific-research-and-development-services-global-market-report

Small Animal Imaging (In-Vivo) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Acne Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: